VIVO BIO TECH LTD. - 511509 - Un-Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022.
Vivo Bio Tech Limited has submitted with the exchange the Un-Audited Standalone & Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022. VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Un-Audited Standalone & Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2022.
Vivo Bio Tech Limited has submitted with the exchange the Outcome of Board meeting for the item transacted for apporval of Un-Audited Standalone & Consolidated Financial Results for the quarter and nine months ended December 31, 2022. VIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Un-Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022.
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the Quarter and Nine Months ended December 31, 2022. VIVO BIO TECH LTD. - 511509 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Vivo Bio Tech Limited has submitted with the exchange the certificate received from M/s. Aarthi Consultants Private Limited (Registrar and Share Transfer Agent), for the period from October 01, 2022 to December 31, 2022 under SEBI (Depositories and Participants) Regulations, 2018. VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Vivo Bio Tech Limited has informed the exchange that the Company has today allotted 27,000 Equity Shares under Vivo Bio Employees Stock Option Scheme, 2016 to the eligible employees of the Company pursuant to the exercise of options granted. Consequently, the issued and Subscribed Share Capital of the Company stands increased to Rs. 14,90,35,200 divided into 1,49,03,520 Equity Shares of Rs.10/- each. VIVO BIO TECH LTD. - 511509 - Closure of Trading Window
Vivo Bio Tech Limited has informed the exchange that, pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and Company's Internal Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters and Designated Persons of the Company, the Trading Window for dealing in the securities of the Company shall remain Closed for all insiders including Designated Persons and their immediate relatives from January 01, 2023 till the end of 48 hours after the declaration of the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 2022. VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Outcome Of Board Meeting Dated December 21, 2022
Vivo Bio Tech Limited has informed the exchange that with reference to the Company''s letter dated December 12, 2022, the Board of Directors of the Company at their meeting held today, i.e. Wednesday, December 21, 2022, inter-alia, transacted the following business: 1. Approval for engagement/appointment of Consultants or intermediaries for the proposed issuance of equity shares/warrants by way of a preferential allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required. VIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Proposal For Issuance Of Equity Shares/Warrants Under Preferial Allotment
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/12/2022 ,inter alia, to consider and approve 1. Proposal for issuance of equity shares/warrants by way of a preferential allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required. 2. Convening of an Extra-Ordinary General Meeting or Postal Ballot process to seek approval of the shareholders in respect of the aforesaid proposal of preferential allotment, as required. VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Vivo Bio Tech Limited has submitted with the exchange the copies of advertisement issued in newspapers on November 16, 2022, in 'Financial Express' in English Language and in 'Nava Telangana' in Telugu Language, with respect to the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2022. VIVO BIO TECH LTD. - 511509 - Un-Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Half-Year Ended September 30, 2022.
Vivo Bio Tech Limited has submitted with the exchange the Un-Audited Standalone & Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2022.